Nishigaki K | Drug Evaluation Committee The Japan Pharmaceutical Manufacturers Association (jpma):fuji Research La
スポンサーリンク
概要
- NISHIGAKI Keijiの詳細を見る
- 同名の論文著者
- Drug Evaluation Committee The Japan Pharmaceutical Manufacturers Association (jpma):fuji Research Laの論文著者
関連著者
-
Hirano Fumiya
Drug Evaluation Committee The Japan Pharmaceutical Manufacturers Association (jpma):research & D
-
Numa Toshiaki
Drug Evaluation Committee The Japan Pharmaceutical Manufacturers Association (jpma):toxicology Team
-
Endo Y
Drug Evaluation Committee The Japan Pharmaceutical Manufacturers Association (jpma):clinical Safety
-
Nishigaki K
Drug Evaluation Committee The Japan Pharmaceutical Manufacturers Association (jpma):fuji Research La
-
Matsuzawa T
Drug Evaluation Committee The Japan Pharmaceutical Manufacturers Association (jpma)
-
Mineshima H
Drug Safety Res. Laboratories (kakamigahara) Eisai Co. Ltd.
-
Ogasawara Hiroyuki
Drug Evaluation Committee The Japan Pharmaceutical Manufacturers Association (jpma):medical Research
-
Okuda Yasuyuki
Working Group For Reproductive Toxicology Non-clinical Evaluation Subcommitee Drug Evaluation Commit
-
MINESHIMA Hiroshi
Working Group for Reproductive Toxicology, Non-clinical Evaluation Subcommitee, Drug Evaluation Comm
-
NUMA Toshiaki
Working Group for Reproductive Toxicology, Non-clinical Evaluation Subcommitee, Drug Evaluation Comm
-
NISHIGAKI Keiji
Working Group for Reproductive Toxicology, Non-clinical Evaluation Subcommitee, Drug Evaluation Comm
-
ENDO Yoshihiko
Working Group for Reproductive Toxicology, Non-clinical Evaluation Subcommitee, Drug Evaluation Comm
-
OGASAWARA Hiroyuki
Working Group for Reproductive Toxicology, Non-clinical Evaluation Subcommitee, Drug Evaluation Comm
-
HIRANO Fumiya
Working Group for Reproductive Toxicology, Non-clinical Evaluation Subcommitee, Drug Evaluation Comm
-
MIYAKE Yukio
Working Group for Reproductive Toxicology, Non-clinical Evaluation Subcommitee, Drug Evaluation Comm
-
MATSUZAWA Toshiaki
Working Group for Reproductive Toxicology, Non-clinical Evaluation Subcommitee, Drug Evaluation Comm
-
MINESHIMA Hiroshi
Drug Evaluation Committee, the Japan Pharmaceutical Manufacturers Association (JPMA)
-
ENDO Yoshihiko
Drug Evaluation Committee, the Japan Pharmaceutical Manufacturers Association (JPMA)
-
OGASAWARA Hiroyuki
Drug Evaluation Committee, the Japan Pharmaceutical Manufacturers Association (JPMA)
-
NISHIGAKI Keiji
Drug Evaluation Committee, the Japan Pharmaceutical Manufacturers Association (JPMA)
-
MATSUZAWA Toshiaki
Drug Evaluation Committee, the Japan Pharmaceutical Manufacturers Association (JPMA)
-
Miyake Yukio
Working Group For Reproductive Toxicology Non-clinical Evaluation Subcommitee Drug Evaluation Commit
著作論文
- Se2-2 How pharmaceutical companies meet the ICH guideline for reproductive toxicity studies. : Consideration from a survey carried out by JPMA(Proceedings of the 27th Annual Meeting)
- IMPACT OF GLOBALIZATION UNDER THE ICH GUIDELINES ON THE CONDUCT OF REPRODUCTIVE TOXICITY STUDIES : REPORT ON CURRENT STATUS IN JAPAN, EUROPE AND THE US BY QUESTIONNAIRE SURVEY